Clinical Trials Browser

Phase 2 × Costs and Cost Analysis × 90 days × Clear all

NCT05307939 2026-04-13

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Phase 2 Recruiting

Oropharyngeal Neoplasms